Drawing for THE PARATEK DIFFERENCE

USPTO serial 87660980

THE PARATEK DIFFERENCE

Reviewed by CopyMark Law Group

Status 606
Filing date
Status date
Registration date
—
Examiner
I, DAVID C
Law office
INTENT TO USE SECTION

What this means

This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.

Need help with THE PARATEK DIFFERENCE?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Keith Toms, Esq.

KEITH TOMS, ESQ. MCCARTER & ENGLISH, LLP265 FRANKLIN STREETBOSTON, MA 02110UNITED STATES

Goods and services

ClassDescriptionStatusFirst use
042Conducting early evaluations in the field of new pharmaceuticals; Development of pharmaceutical preparations and medicines; Pharmaceutical products development; Pharmaceutical research and development; Research and development in the pharmaceutical and biotechnology fields; Research in the field of pharmaceuticals, drugs and antibioticsACTIVE—
044Medical information services; providing medical information in the fields of health, medicine, and pharmaceuticals for the treatment of infectious disease; Medical information services, namely, providing medical information to physicians, healthcare professionals, and patients on the topics of health issues, use of pharmaceutical products, and health awareness in the field of infectious diseasesACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

Latest event (MAB6): The intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.

DateCodeEventWhat it means
Jun 8, 2020MAB6ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILEDThe intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.
Jun 8, 2020ABN6ABANDONMENT - NO USE STATEMENT FILEDThe intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.
Oct 29, 2019EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Oct 25, 2019EX2GSOU EXTENSION 2 GRANTED—
Oct 25, 2019EXT2SOU EXTENSION 2 FILED—
Oct 25, 2019EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
May 4, 2019EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
May 2, 2019EX1GSOU EXTENSION 1 GRANTED—
May 2, 2019EXT1SOU EXTENSION 1 FILED—
May 2, 2019EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Nov 6, 2018NOAMNOA E-MAILED - SOU REQUIRED FROM APPLICANTA Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date.
Sep 11, 2018NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Sep 11, 2018PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Aug 22, 2018NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Aug 9, 2018ALIEASSIGNED TO LIE—
Jul 30, 2018CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Jul 28, 2018TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Jul 27, 2018TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED—
Jul 27, 2018CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Jul 27, 2018TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Feb 6, 2018GNRNNOTIFICATION OF NON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Feb 6, 2018GNRTNON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Feb 6, 2018CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Feb 6, 2018DOCKASSIGNED TO EXAMINER—
Nov 4, 2017NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Oct 30, 2017NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance